Anbio Biotechnology (NASDAQ:NNNN) Trading Up 8.2% – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price traded up 8.2% on Thursday . The company traded as high as $15.80 and last traded at $16.5070. Approximately 20,983 shares were traded during trading, a decline of 52% from the average session volume of 43,304 shares. The stock had previously closed at $15.25.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Anbio Biotechnology Trading Up 1.1%

The company’s fifty day moving average is $25.40.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.